Better prognosis with surgery for HPV-linked oropharyngeal SCC

Better prognosis with surgery for HPV-linked oropharyngeal SCC

(HealthDay)—Patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (SCC) have higher five-year overall survival (OS) and disease-specific survival (DSS) rates after surgery alone, according to a study published online July 10 in Head & Neck.

Martina A. Broglie, M.D., from Kantonsspital St. Gallen in Switzerland, and colleagues conducted a retrospective analysis of survival estimates in patients with surgically treated oropharyngeal SCC, stratifying by tumoral positivity for HPV and risk-of-death categories.

The researchers found that HPV-associated oropharyngeal SCC correlated with higher five-year OS (80 versus 62 percent; P = 0.01) and DSS (92 versus 76 percent; P = 0.03) rates after alone. Higher survival rates were seen for patients in the low-risk category (OS: 91 percent; DSS: 99 percent), compared with the intermediate-risk (OS: 63 percent; DSS: 83 percent) and high-risk (OS: 61 percent; DSS: 75 percent) groups.

"Nonsmokers with HPV-positive oropharyngeal SCC have a better prognosis than smokers with HPV-positive oropharyngeal SCC and also than with HPV-negative tumors when treated by surgery alone," the authors write.

Explore further

Smoking, T4 tumors up distant mets in HPV+ oropharyngeal CA

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Better prognosis with surgery for HPV-linked oropharyngeal SCC (2017, July 18) retrieved 28 July 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments